ipharmaservicesApr 2Inflammatory bowel disease | Crohn's disease | Ulcerative colitis | News | Updates | 2024 | iPharmaCenterZeposia failed to meet the efficacy endpoints in patients with Crohn's disease Bristol Myers Squibb has provided an update on the...
ipharmaservicesMar 28Japan Drug Approvals | March 2024 | PMDA | MHLW Updates | iPharmaCenterApproval of Truqap plus Faslodex Granted in Japan for Patients Dealing with Advanced Hormone Receptor-Positive Breast Cancer Beyfortus...